Morning Overview on MSN
A VA study of 588,000 patients ties GLP-1 drugs to a 35% higher risk of vision loss
Millions of Americans taking GLP-1 receptor agonists for type 2 diabetes or weight loss now face a new safety question. A ...
Morning Overview on MSN
A huge Lancet study says statins don’t cause most of the side effects on their labels
Millions of people who take statins for heart disease prevention have been warned about dozens of possible side effects on ...
I didn’t even realize that those were questions you could ask,” he says, “and then that there were philosophical disciplines ...
In patients with septic shock, early vasopressor therapy plus restricted fluid administration does not improve 90-day outcomes compared with greater fluid administration with later vasopressor use.
The trial is real, and it is a meaningful step. It is also, by design, small, tightly controlled, and years away from ...
Background Comparative evidence on the diagnostic yield of endobronchial ultrasound (EBUS)-guided sampling techniques for ...
A recent study found that a combination of dietary fibers effectively alleviated chronic constipation, enhancing bowel ...
MedPage Today on MSN
May as Well Get COVID and Flu Shots on the Same Day, Study Says
Coadministration was not associated with an increased risk of side effects ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States.FDA agrees with the clinical protocol ...
Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43% and 36% versus 12% — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results